Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Home » Publications » Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Questo sito utilizza i cookie per analisi statistiche: continuando la navigazione ne accetti l'uso
